AMRI licenses Teewinot's cannabinoid analytical standard production tech

By Gareth Macdonald contact

- Last updated on GMT

iStock/Thom_Morris
iStock/Thom_Morris

Related tags: Research, Technology

AMRI has licensed technology needed to make an analytical standard drug firms working with cannabinoids can use for research and quality control.

The technology used to make the CBCA analytical standard was developed by Teewinot Life Sciences.

Teewinot CEO Jeffrey Korentur told us “researchers will be able to use the standard validate and confirm that the compound they are using either is, or is not, CBCA. Standards may have other uses in research and development including preliminary efficacy studies​.”

He added that: “AMRI is licensed to use our technology to manufacture and sell the CBCA analytical standard​.”

Teewinot has a suite of biosynthetic technologies it uses to make cannabinoid-based compounds in micro-organisms.

The idea is that the approach is faster and more consistent than plant-based production.

Scale-up

The agreement with AMRI is seperate to the deal Teewinot has with the US contractor to scale up the cannabinoid production process.

Korentur told us: “Our scale up is in progress now, and we anticipate being able to produce kilogram quantities of GMP manufactured cannabinoids by Q1 2017​.”

Tech license

News of the deal comes a week after Florida-based Teewinot licensed rights to its cannabinoid active pharmaceutical ingredient (API) manufacturing technology to Nemus Biosciences.

That agreement was signed days after Teewinot’s Ireland-based subsidiary, Full Spectrum Laboratories, was granted a US patent​ for the technology. 

Related news

Show more

Related products

show more

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

Related suppliers

Follow us

Products

View more

Webinars